However, neither a specific adaptive nor maladaptive role for ChREBP has been clearly established in the development of steatosis or the progression of steatosis to more advanced forms of NAFLD involving inflammation or fibrosis. This evidence concerns the gene MLXIPL and metabolic dysfunction-associated steatotic liver disease.